文献速递神经肌肉病

丹麦1985至2020年重症肌无力患者死亡率:基于人群的队列研究

Mortality in Myasthenia Gravis in Denmark From 1985 to 2020: A Population-Based Cohort Study.
PubMed 文献 · Neurology · 2025-06-03

该研究利用丹麦全国健康登记数据,将2110例重症肌无力(MG)患者按年龄、性别和诊断日期与一般人群1:10匹配,分析短期(<1年)和长期(1-5年)死亡率。结果显示MG患者短期死亡风险显著升高(HR 1.8,95%CI 1.5-2.3),长期风险轻度升高(HR 1.3,95%CI 1.1-1.5),2015至2020年≥75岁患者短期死亡率上升尤为明显(HR 2.8,95%CI 1.8-3.6)。

要点

  • MG患者诊断后第一年死亡风险约为一般人群的1.8倍。
  • 长期(1-5年)死亡风险轻度升高,HR为1.3。
  • 2015至2020年≥75岁患者短期死亡风险达HR 2.8,需密切监测。

核心结论

  • MG患者死亡率仍升高,尤其在诊断后第一年的老年患者中,强调早期干预和密切监测的重要性。

研究设计与样本

  • 基于丹麦全国健康登记的匹配队列研究,纳入1985至2020年2110例MG患者和21100例一般人群对照。

主要发现

  • 短期累积死亡率MG患者为4.8%,一般人群为2.6%,匹配HR为1.8(95%CI 1.5-2.3)。
  • 长期死亡率为HR 1.3(95%CI 1.1-1.5)。
  • 2015至2020年短期死亡率上升,≥75岁患者HR为2.8(95%CI 1.8-3.6)。
  • 合并症调整后短期死亡率HR降至1.6(95%CI 1.3-2.0),长期死亡率与一般人群一致。

临床怎么用

  • 对MG患者,尤其是老年患者,诊断后第一年应加强干预和密切监测以降低死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Myasthenia gravis (MG) is a life-threatening disease associated with elevated mortality, primarily in the first years after diagnosis. We determined short-term (<1 year) and long-term (1-5 years) mortality for patients with MG compared with the general population. METHODS: Using nationwide health registers, we identified patients with MG and matched 1:10 with the general population by age, sex, and diagnostic index date from 1985 to 2020. We calculated matched hazard ratios (HRs) using Cox regression analysis, stratified by sex, age, period, and baseline comorbidities, and performed comorbidity-adjusted analyses. RESULTS: Our cohort encompassed 2,110 patients (50.2% female) and 21,100 from the general population, with 77.3% aged younger than 75 years. Short-term cumulative mortality was 4.8% in patients with MG and 2.6% in the general population, yielding a HR of 1.8 (95% CI 1.5-2.3). Long-term mortality was 1.3 (95% CI 1.1-1.5). Short-term mortality rose from 2015 to 2020, especially in patients aged 75 years or older (HR 2.8, 95% CI 1.8-3.6). Comorbidity-adjusted analyses decreased short-term mortality (HR 1.6, 95% CI 1.3-2.0), and long-term mortality aligned with the general population. DISCUSSION: MG mortality remains elevated, especially in the first year after diagnosis in older patients, underlining the importance of early intervention and close monitoring.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Jul Jarbæk Nielsen J, Levison L, Andersen H, et al. Mortality in Myasthenia Gravis in Denmark From 1985 to 2020: A Population-Based Cohort Study. Neurology. 2025. PMID: 40460351. doi:10.1212/WNL.0000000000213745

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。